RAD51D and cancer: We have not discovered any pathogenic variants in RAD51D, STK11, PTEN, and TP53 genes in our non-cancer affected study population of 7091 participants; this is not surprising since most of these genes had none to a very low pathogenic variant prevalence in control populations in previous studies66.